Labcorp Holdings Inc. (LH)
NYSE • Healthcare
Last close at November 20, 2026 at 21:00 UTC
Metrics Over Time
Where the Money Goes
Q3 2026In plain terms: out of every $100 in revenue, Labcorp Holdings Inc. keeps $7 as net profit.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Feb 16
in 86 daysQ1 2027% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Labcorp beat expectations on both the top and bottom line in preliminary results for the third fiscal quarter of 2026, reported October 28, 2026, with revenue rising 6.9% to about $3.8 billion, driven by its diagnostic laboratory testing and related research support activities. Adjusted EPS of $4.78 topped the $4.64 estimate (+3%) and was up 14.4% from $4.18 a year ago, while revenue of $3.810 billion topped the $3.759 billion estimate (+1.4%) and increased from about $3.6 billion a year earlier. Profitability held with gross margin at ~29% and operating margin near 11%, alongside gross profit of roughly $1.1 billion and operating income of about $402 million. Net income edged up 0.7% to around $262.8 million, up from roughly $261.1 million a year ago. The company generated operating cash flow of about $563.8 million and paid roughly $58.2 million in dividends. For the next period, consensus calls for EPS of $4.47 on revenue of $3.739 billion.
About Labcorp Holdings Inc.
Labcorp Holdings Inc. provides diagnostic laboratory services through a healthcare business centered on medical testing and related research support, and its shares trade on the NYSE under the ticker LH. In FY2025, the company generated $14.0 billion in revenue in the Medical - Diagnostics & Research field.
Today's Snapshot
The day ended with LH slightly lower at 367.29, in line with a flat sector. LH closed within 2.1% of its 52-week high of 375.10. Baird, an investment bank, raised its Labcorp price target to $411 from $396.
Trading Volume
Below 10d avg (615.4K)
447.1K
vs S&P 500 Today
Strong Outperformance
+3.06%
Updated: November 20, 2026 at 21:12 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$300.99 - $367.79Buy
- RSI (14)62.35Neutral
- Stochastic %K (14, 3, 3)74.75Neutral
- MACD Level (12, 26)10.58Neutral
Peers & Related Assets
Get premium market insights delivered directly to your inbox.